European and U.S. chemical companies have been making moves to strengthen their R&D operations in Japan, taking particular aim at...
R&D
Siam Bioscience Readies to Commercialize Monoclonal Antibodies
Thai biopharmaceuticals firm Siam Bioscience Co. Ltd. is planning to begin commercial business operations for monoclonal antibodies in 2019. As...
New Alliance Set to Form in Battle Against Ocean Plastic Problem
With backing from the Ministry of Economy, Trade and Industry (METI), a host of companies making up the supply chain...
